Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

32.80
-0.2395-0.72%
Post-market: 32.800.00000.00%16:10 EDT
Volume:171
Turnover:6K
Market Cap:13.12M
PE:- -
High:32.80
Open:33.04
Low:32.80
Close:33.04
52wk High:34.86
52wk Low:25.79
Shares:400.00K
Float Shares:400.00K
Volume Ratio:0.06
T/O Rate:0.04%
Dividend:0.08
Dividend Rate:0.25%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

ALEBUND-B Wins US FDA Nod to Start Trial of Novel IgA Nephropathy Drug AP308

Stock News
·
Sep 08

Johnson & Johnson Innovation Names Silvia Chen Head of JLABS Shanghai

Reuters
·
Sep 08

Merck CEO Davis, R&D Head Li to Speak at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 08

Guggenheim Adjusts Price Target on Merck & Co. to $170 From $146, Maintains Buy Rating

MT Newswires Live
·
Sep 08

Merck & Co Inc : Guggenheim Raises Target Price to $170 from $146

THOMSON REUTERS
·
Sep 08

MediciNova to Participate in Two Investor Conferences in September

GlobeNewswire
·
Sep 08

Cholesterol Drug Trial Setback Casts Doubt on Multi-Billion Rivalry

Deep News
·
Sep 08

Fosun Pharma's Subsidiary Obtains Regulatory Nod for FXS5626 Tablet Trial in Vitiligo Indication

Stock News
·
Sep 08

Pharmaceutical Giant's Shares Plunge Nearly 10% Following Triple Clinical Trial Setbacks

Deep News
·
Sep 08

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Merck & Company (MRK)

TIPRANKS
·
Sep 08

Medprin Regenerative Medical Technologies Advances Absorbable Hemostatic Gel to Clinical Trials

Stock News
·
Sep 08

Merck KGaA (0O14) Gets a Hold from Barclays

TIPRANKS
·
Sep 08

Gilead Sciences (GILD) Receives a Buy from Bernstein

TIPRANKS
·
Sep 08

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Sep 08

Aliko Scientific accelerates global oncology diagnostics push with Partner International deal

TIPRANKS
·
Sep 08

CSPC Pharma Initiates Phase II Trial of SYH2085 Tablet for Uncomplicated Influenza in Chinese Adults

Stock News
·
Sep 07

HENGRUI PHARMA Advances Pipeline with SHR-1179 Injection Clinical Trial Approval

Stock News
·
Sep 07

Hengrui Pharma Subsidiary Gains Clinical Trial Approval for Weight Management Drug Candidate

Stock News
·
Sep 07

Chongqing Zhifei Biological Receives Clinical Trial Approval for Recombinant Rotavirus Subunit Vaccine

Stock News
·
Sep 07

Hualan Vaccine's Novel Influenza mRNA Vaccine Clears Clinical Trial Hurdle, No Domestic Competitors Yet

Stock News
·
Sep 07